Oral Hygiene and Systemic Inflammation (Perio-Hygiene 1.0)
The Impact of Correct and Efficient Oral Hygiene Maneuvers on Markers of Systemic Inflammation and Overall Well-being.
1 other identifier
interventional
140
1 country
1
Brief Summary
The purpose of the study is to evaluate the impact of oral hygiene changes (drastic plaque and gingival inflammation reduction) on markers of systemic inflammation and indicators of oral health related quality of life and other aspects related to overall well-being. The primary objective is to assess a possible reduction of systemic inflammation as measured through blood bio-markers one month after drastic changes of plaque accumulation. As primary outcome measure, the level of high-sensitive C-reactive protein (hs-CRP) will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2019
CompletedFirst Posted
Study publicly available on registry
February 20, 2019
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2021
CompletedNovember 7, 2022
November 1, 2022
2.1 years
February 15, 2019
November 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline of High sensitivity C-Reactive Protein (hsCRP) at 1 month
analyzed though blood sampling. Unit of measure: mg/L
Difference of values of the markers collected at Baseline and 1 month after treatment
Secondary Outcomes (12)
Change from baseline of Interleukin 6 at 1 month
Difference of values of the markers collected at Baseline and 1 month after treatment
Vitamin D
Collected at Baseline
Full-mouth plaque score (FMPS)
Measured at Baseline and 1 month after treatment
Full-mouth bleeding score (FMBS)
Measured at Baseline and 1 month after treatment
Pocket probing depth (PPD)
Measured at Baseline and 1 month after treatment
- +7 more secondary outcomes
Study Arms (2)
Control Group
NO INTERVENTION70 patients not receiving oral hygiene instructions or devices and continuing with their routine oral hygiene habits
Test Group
ACTIVE COMPARATOR70 patients receiving intense oral hygiene instructions assisted by specific software or devices as well as oral hygiene (OH) tools (electric toothbrush, interdental floss, toothpaste) Thus, interventions will consist of. * Oral Hygiene Instruction (OHI) * Professional supragingival scaling and polishing
Interventions
OHI will be given focusing on electric toothbrushing as first instance and subsequently focusing on interdental cleaning. OHI will be delivered by trained dental hygienist/periodontist. In the first phase the clinician will explain and show the technique to the patient. The patient will be then invited to perform the technique. Each phase will be assisted and monitored by the clinician. Overall, this sequence may be repeated as many times as the clinician would deem appropriate.
Patients will receive a session of professional supragingival scaling and polishing, that consists of removal of dental plaque and dental calculus from the surface of a tooth, with great care in performing exclusively coronal maneuver. No instrumentation or exploring of the gingival crevice/ sulcus will be performed. Instrumentation will be performed by a trained dental hygienist/periodontist.
Eligibility Criteria
You may qualify if:
- male or female, 18 to 79 of age, of any race/ethnicity;
- presence of at least 20 teeth;
- ≤ 2 untreated dental caries;
- presence of relevant plaque accumulation as shown by Full Mouth Plaque Scores (FMBS) \>50%.
- presence of relevant periodontal/gingival inflammation as shown by FMBS \> 35%
You may not qualify if:
- pregnancy and breast feeding;
- patients undergoing pharmacological treatment capable of reducing CRP such as statins or chronic anti-inflammatory treatment,
- current or past (≤ 30 days) systemic or local antibiotic therapy;
- heavy smokers (over 20 cigarettes per day or pipe or cigar);
- patients undergoing orthodontic treatment;
- patients not capable to comply with given instruction or administrative issues related to the study
- dental or periodontal conditions (e.g., deep caries, periodontal abscess) requiring urgent treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Pisa
Pisa, 56126, Italy
Related Publications (1)
Peric M, Marhl U, Gennai S, Marruganti C, Graziani F. Treatment of gingivitis is associated with reduction of systemic inflammation and improvement of oral health-related quality of life: A randomized clinical trial. J Clin Periodontol. 2022 Sep;49(9):899-910. doi: 10.1111/jcpe.13690. Epub 2022 Jul 17.
PMID: 35762095DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor will not be present during explanation of oral hygiene maneuvers. Moreover, participants will be asked not to mention about techniques and group participation to the outcome assessors.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Dentistry
Study Record Dates
First Submitted
February 15, 2019
First Posted
February 20, 2019
Study Start
April 1, 2019
Primary Completion
May 4, 2021
Study Completion
May 4, 2021
Last Updated
November 7, 2022
Record last verified: 2022-11